Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
暂无分享，去创建一个
Kwang Su Kim | Shinji Watanabe | H. Ebihara | S. Fukushi | S. Iwami | Tadaki Suzuki | H. Hasegawa | Yoshimasa Takahashi | N. Kishida | S. Iwanami | H. Ohashi | Kaho Shionoya | K. Watashi | Takayuki Hishiki | S. Moriyama | D. Akazawa | Y. Kuroda | Souichi Yamada | K. Tsuchimoto | H. Kinoshita | Ken Maeda | J. Woo | Tsukasa Yamamoto | Hirofumi Ohashi | Saya Moriyama | Koichi Watashi